GlassScriptPhysician profile
Jaimie Te
NPI 1548996341
$570.03
in general payments reported to CMS, 2019-2025
9 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $20.58 · 2024: $257 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $154.97 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Sumitomo Pharma America, INC. | $99.58 | 2024-2025 | Gemtesa |
| Vivus LLC | $62.03 | 2024 | Pancreaze |
| Radius Health, INC. | $48.79 | 2025 | Tymlos |
| Glaxosmithkline, LLC. | $47.16 | 2024-2025 | Arexvy, Shingrix |
| Exact Sciences Corporation | $42.11 | 2025 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $39.17 | 2025 | Gvoke Hypopen |
| Almatica Pharma LLC | $31.07 | 2024 | Loreev Xr |
| Astrazeneca Pharmaceuticals LP | $24.57 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaimie Te listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.